Niclosamide

氯硝柳胺

Report date: 2026/05/03 20:00:15
NME

Base Information

Drug NameNiclosamide
Drug Alias Nameniclosamidaniclosamideniclosamidumниклосамидنيكلوساميد +[20] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionVirus replication inhibitorsWnt signalling pathway inhibitors
TargetsNot applicable
Therapy Area/IndicationsUlcerative proctitisCoronavirus Disease 2019 (COVID-19)Diabetic Nephropathies +[11] 
Global Approved IndicationsAscariasis
Approved Indications in ChinaAscariasis
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryUnited StatesUkraineTurkey +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesNeurobo Pharmaceuticals IncTufts Medical Center IncStanford University +[6] 
Inactive CompaniesImuneks Farma Ilac San. Tic AsCharité Research Organization GmbhEntero Therapeutics Inc +[9] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Diabetic NephropathiesLeukemia, Myeloid, Acute +[4] 
Inactive IndicationsUlcerative proctitisProctocolitisColitis, Ulcerative +[7] 

Other Information

ATC CodeP02DA01
Related LinksWikipediaDrugBankKEGG